Nancy E. Davidson
Fred Hutchinson Cancer Center
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Advanced Breast Cancer Therapies
Strong evidence · 3 supporting papers · latest 2026
Breast Cancer Treatment Studies
Strong evidence · 6 supporting papers · latest 2026
Cancer survivorship and care
Strong evidence · 2 supporting papers · latest 2025
Hedgehog Signaling Pathway Studies
Strong evidence · 1 supporting paper · latest 2025
Cell Adhesion Molecules Research
Strong evidence · 1 supporting paper · latest 2025
Cancer Cells and Metastasis
Solid evidence · 2 supporting papers · latest 2026
Ovarian function and disorders
Solid evidence · 1 supporting paper · latest 2025
Reproductive Biology and Fertility
Solid evidence · 1 supporting paper · latest 2025
Publications (15)
Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts
2025DOIPMID 40975064
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer
2025DOIPMID 41005288
Abstract GS2-02: Impact of Tamoxifen Only after Breast Conservation Surgery for "Good Risk" Duct Carcinoma in Situ: Results from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trial
2025DOI
Comparisons of Physical Activity and Sedentary Behavior Measurements From the ActiGraph, International Physical Activity Questionnaire, and Fitbit in Women With History of Breast Cancer
2025DOIPMID 41325737
Real‐World Practice Patterns in Diagnosis and First‐Line Treatment in Metastatic Breast Cancer
2026DOIPMID 42365454
Prognostic value of patient‐reported depression in women with hormone‐responsive early breast cancer in TEXT and SOFT
2025DOIPMID 40986647
Impact of Tamoxifen Only After Lumpectomy for “Good-Risk” Duct Carcinoma In Situ: Combined Analysis of the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trials
2026DOIPMID 42114785
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
2026DOIPMID 41890029
Incidental discovery of second primary lung tumors in breast cancer patients: an institutional case series
2026DOIPMID 41949764
346P Randomized window trial comparing molecular impact of SERD vs AI vs tamoxifen in ILC (TBCRC 037)
2025DOI
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
2026DOIPMID 42115634
Inhibition of histone demethylase LSD1 suppresses CD47 expression and enhances efficacy of CD47 blockade in breast cancer
2026DOIPMID 42242864
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
2026DOI
Abstract P3-08-23: Using a SMART Approach to Culturally-Adapt and Remotely Deliver a Weight Loss Intervention for Latina Breast Cancer Survivors: The ¡Vida! Study Methods
2025DOI
Abstract B099: ¡Vida! SMART Trial: Implementation readiness and early adaptation insights from a culturally tailored weight loss trial for Latina breast cancer survivors
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Fred Hutchinson Cancer Center
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27